Reuters logo
BRIEF-Anavex Life Sciences reports PK and PD data from Phase 2a trial of ANAVEX2-73
October 12, 2017 / 11:49 AM / 7 days ago

BRIEF-Anavex Life Sciences reports PK and PD data from Phase 2a trial of ANAVEX2-73

Oct 12 (Reuters) - Anavex Life Sciences Corp

* Anavex Life Sciences reports PK and PD data from Phase 2a trial of ANAVEX2-73 in mild-to-moderate Alzheimer’s Disease patients

* Anavex Life Sciences Corp - ‍ANAVEX2-73 demonstrates desirable PK/PD properties

* Anavex Life Sciences Corp - ‍clear concentration-effect relationship between ANAVEX2-73 and study measurements​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below